These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8088289)

  • 1. Preparation and clinical evaluation of technetium-99m dimercaptosuccinic acid for tumour scintigraphy.
    Hirano T; Tomiyoshi K; Zhang YJ; Ishida T; Inoue T; Endo K
    Eur J Nucl Med; 1994 Jan; 21(1):82-5. PubMed ID: 8088289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.
    Ugur O; Kostakğlu L; Güler N; Caner B; Uysal U; Elahi N; Haliloğlu M; Yüksel D; Aras T; Bayhan H; Bekdik C
    Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
    Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
    J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA.
    Yen TC; King KL; Yang AH; Liu RS; Yeh SH
    J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
    Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
    J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of In-111 pentetreotide, Tc-99m (V)DMSA and I-123 mlBG scintimaging in neural crest tumors.
    Limouris GS; Giannakopoulos V; Stavraka A; Toubanakis N; Vlahos L
    Anticancer Res; 1997; 17(3B):1589-92. PubMed ID: 9179199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A convenient method for the preparation of 99mTc-labelled pentavalent DMSA and its evaluation as a tumour imaging agent.
    Babbar A; Kashyap R; Chauhan UP
    J Nucl Biol Med (1991); 1991; 35(2):100-4. PubMed ID: 1657203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentavalent Tc-99m DMSA accumulation in a medullary carcinoma of the thyroid.
    Hirano T; Otake H; Watanabe N; Oriuchi N; Fukuda T; Endo K
    Clin Nucl Med; 1997 May; 22(5):339-40. PubMed ID: 9152545
    [No Abstract]   [Full Text] [Related]  

  • 9. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
    Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
    J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a DMSA kit for instant preparation of 99mTc(V)-DMSA for tumour and metastasis scintigraphy.
    Chauhan UP; Babbar A; Kashyap R; Prakash R
    Int J Rad Appl Instrum B; 1992 Nov; 19(8):825-30. PubMed ID: 1330991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.
    Hilditch TE; Connell JM; Elliot AT; Murray T; Reed NS
    J Nucl Med; 1986 Jul; 27(7):1150-3. PubMed ID: 3014086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliable preparation of 99mTc (V) DMSA by a simple modified method using a commercial kit for 99mTc (III) DMSA.
    Washburn LC; Biniakiewicz DS; Maxon HR
    Nucl Med Biol; 1995 Jul; 22(5):689-91. PubMed ID: 7581181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen bubbling can improve the labelling of pentavalent technetium-99m dimercaptosuccinic acid.
    Kobayashi H; Suzuki KH; Sakahara H; Yao ZS; Yokoyama A; Konishi J
    Eur J Nucl Med; 1995 Jun; 22(6):559-62. PubMed ID: 7556304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET imaging of recurrent medullary thyroid cancer.
    Simon GH; Nitzsche EU; Laubenberger JJ; Einert A; Moser E
    Nuklearmedizin; 1996 Jun; 35(3):102-4. PubMed ID: 8710526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Scintigraphy of medullary carcinoma of the thyroid by new radiopharmaceuticals].
    Tada J; Konishi J; Torizuka K; Makimoto K; Miyauchi A
    Rinsho Hoshasen; 1984 Sep; 29(9):1043-4. PubMed ID: 6096600
    [No Abstract]   [Full Text] [Related]  

  • 16. Technetium-99m-pentavalent dimercaptosuccinic acid uptake in Hurthle cell tumor of the thyroid.
    Vergara E; Lastoria S; Varrella P; Lapenta L; Salvatore M
    J Nucl Biol Med (1991); 1993 Jun; 37(2):65-8. PubMed ID: 8396979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinoma.
    Verga U; Muratori F; Di Sacco G; Banfi F; Libroia A
    Henry Ford Hosp Med J; 1989; 37(3-4):175-7. PubMed ID: 2576958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma.
    Hoefnagel CA; Delprat CC; Zanin D; van der Schoot JB
    Clin Nucl Med; 1988 Mar; 13(3):159-65. PubMed ID: 2838213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 111In-octreotide and 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma.
    Berná L; Cabezas R; Mora J; Torres G; Estorch M; Carrió I
    J Endocrinol; 1995 Feb; 144(2):339-45. PubMed ID: 7706986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive scintigraphy of medullary thyroid cancer using 201Tl and alkalized 99mTc-DMSA.
    Holub V; Nĕmec J; Neradilová M; Benová M; Blazek T; Dusek M
    Radiobiol Radiother (Berl); 1987; 28(5):640-2. PubMed ID: 2831559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.